These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 8171626

  • 41. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
    Gundlach M, Oluwole SF, Pohland CC, Broelsch CE, Hardy MA.
    Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival.
    Lussow AR, Fanget L, Gao L, Buelow R, Pouletty P.
    Transplant Proc; 1996 Apr; 28(2):571-2. PubMed ID: 8623277
    [No Abstract] [Full Text] [Related]

  • 45. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
    Goss JA, Nakafusa Y, Yu S, Flye MW.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Anti-CD4 therapy induces a donor-specific, organ-nonspecific tolerance in allogeneic kidney graft recipients.
    Kuttler B, Lehmann M, Lacha J, Brock J, Hahn HJ.
    Transplant Proc; 1994 Apr; 26(2):728-9. PubMed ID: 8171628
    [No Abstract] [Full Text] [Related]

  • 48. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
    Steinbrüchel DA, Lillevang ST, Nielsen B, Kemp E.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
    [No Abstract] [Full Text] [Related]

  • 49. The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
    Sablinski T, Sayegh MH, Kut JP, Tilney NL, Milford EL, Kupiec-Weglinski JW.
    Transplantation; 1992 Jan; 53(1):219-21. PubMed ID: 1346346
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Immunologic significance of hepatocytes in tolerance induction after liver transplantation.
    Nakano H, Nakajima Y, Segawa M, Kanehiro H, Murao Y, Nakagawa K, Shiratori T.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):511-3. PubMed ID: 3274815
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effect of intrathymic injection of donor splenocytes on rat small bowel allograft survival.
    Karim MS, Webster GA, Wood RF, Pockley AG.
    Transplant Proc; 1994 Jun; 26(3):1583-4. PubMed ID: 8030047
    [No Abstract] [Full Text] [Related]

  • 54. Mechanisms of tolerance induction by intrathymic injection of allogeneic cells.
    Hoffmann MW, Ruschmeyer D, Pichlmayr R.
    Transplant Proc; 1995 Feb; 27(1):130-1. PubMed ID: 7878890
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Prolongation of rat cardiac allograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC, Lei HY, Jin YT, Lee PH, Lee CJ.
    Transplant Proc; 1994 Aug; 26(4):2323-6. PubMed ID: 8066761
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
    Mottram PL, Pietersz GA, Purcell LJ, Clunie GJ, McKenzie IF.
    Transplant Proc; 1990 Oct; 22(5):2111-2. PubMed ID: 2120812
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
    Motoyama K, Lehmann M, Flye MW.
    Transplant Proc; 1999 Oct; 31(1-2):1237-8. PubMed ID: 10083552
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.